MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

Bibliographic Details
Main Authors:	Chen, Dengyu, Zhang, Yunxia, Wang, Jing, Chen, Junsong, Yang, Cuiping, Cai, Kai, Wang, Xiaoying, Shi, Fangfang, Dou, Jun
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729499/

Similar Items

Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures
by: Chen, Junsong, et al.
Published: (2013)

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138− CD34− tumor stem-like cells in multiple myeloma-bearing mice
by: Yang, Cuiping, et al.
Published: (2013)

Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice
by: Zhang, Yunxia, et al.
Published: (2014)

Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
by: Zhang, Rongrong, et al.
Published: (2015)

Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition
by: Wang, Jing, et al.
Published: (2015)

Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice
by: Yan, Wenxing, et al.
Published: (2013)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
by: Ween, Miranda P., et al.
Published: (2011)

The emerging role of CD44 in regulating skeletal metastasis
by: Hill, A, et al.
Published: (2006)

Expression and Function of CD44 in Epithelial Ovarian Carcinoma
by: Sacks, Joelle D., et al.
Published: (2015)

Rabbit CD200R binds host CD200 but not CD200-like proteins from poxviruses
by: Akkaya, Munir, et al.
Published: (2016)

Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis
by: Wang, Xiaoying, et al.
Published: (2014)

MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene
by: Pu, Youguang, et al.
Published: (2016)

Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis
by: Liu, Yaosheng, et al.
Published: (2015)

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells
by: Arpicco, Silvia, et al.
Published: (2013)

sCD44 overexpression increases intraocular pressure and aqueous outflow resistance
by: Giovingo, Michael, et al.
Published: (2013)

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
by: Zhang, Shi, et al.
Published: (2011)

Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells
by: Liu, Jing, et al.
Published: (2013)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Published: (1996)

CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients
by: Huang, Ruixia, et al.
Published: (2014)

Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling
by: Gorczynski, Reginald M., et al.
Published: (2013)

Erratum to “Evaluation of the Expression of C-Kit (CD117) in Ependymomas and Oligodendrogliomas”
by: Zavalhia, Lisiane Silveira, et al.
Published: (2014)

Evaluation of the Expression of C-kit (CD117) in Ependymomas and Oligodendrogliomas
by: Zavalhia, Lisiane Silveira, et al.
Published: (2012)

KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors
by: Nishida, Haruto, et al.
Published: (2015)

CD117+ cells in the circulation are predictive of advanced prostate cancer
by: Kerr, Bethany A., et al.
Published: (2014)

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
by: Gao, Yan, et al.
Published: (2015)

Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma
by: Vaz, Arokia Priyanka, et al.
Published: (2015)

Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
by: Wang, Huimin, et al.
Published: (2015)

Prevention of tumor metastasis formation by anti-variant CD44
Published: (1993)

CD44 increases the efficiency of distant metastasis of breast cancer
by: McFarlane, Suzanne, et al.
Published: (2015)

CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis
by: Orian-Rousseau, Véronique
Published: (2015)

Another Notch in CD44
by: Dove, Alan W.
Published: (2001)

The liberation of CD44
by: Cichy, Joanna, et al.
Published: (2003)

CD44 in rheumatoid arthritis
by: Naor, David, et al.
Published: (2003)

The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression
by: Basak, Saroj K., et al.
Published: (2013)

Correction: The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression
by: Basak, Saroj K., et al.
Published: (2013)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
by: Adams, April, et al.
Published: (2015)

Characterization of CD200 Ectodomain Shedding
by: Wong, Karrie K., et al.
Published: (2016)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
by: Sliutz, G., et al.
Published: (1995)

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
by: Shi, Jun, et al.
Published: (2013)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
by: Vos, Maria Caroline, et al.
Published: (2016)